INHIBITION OF C-FES EXPRESSION BY AN ANTISENSE OLIGOMER CAUSES APOPTOSIS OF HL-60 CELLS INDUCED TO GRANULOCYTIC DIFFERENTIATION

被引:63
作者
MANFREDINI, R
GRANDE, A
TAGLIAFICO, E
BARBIERI, D
ZUCCHINI, P
CITRO, G
ZUPI, G
FRANCESCHI, C
TORELLI, U
FERRARI, S
机构
[1] UNIV MODENA, INST GEN PATHOL, I-41100 MODENA, ITALY
[2] REGINA ELENA TUMOR INST, EXPTL CHEMOTHERAPY LAB, I-00161 ROME, ITALY
关键词
D O I
10.1084/jem.178.2.381
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The c-fes protooncogene is expressed at high levels in the terminal stages of granulocytic differentiation, but so far no definite function has been attributed to the product of this oncogene. To tackle this problem, the c-fes protooncogene expression has been inhibited in HL60 cells, and fresh leukemic promyelocytes of acute promyelocytic leukemia have been induced to differentiate with retinoic acid (RA) and dimethylsulfoxide (DMSO). Inhibition was obtained by incubating the cells with a specific c-fes antisense oligodeoxynucleotide. It was observed that the cells, rather than differentiating, underwent premature cell death showing the morphological and molecular characteristics of apoptosis. This process was inhibited by granulocyte and granulocyte/macrophage colony-stimulating factor, but not by interleukin 3 (IL-3), IL-6, or stem cell factor. Our present results demonstrate that the loss of cell viability that occurs during the in vitro differentiation of myeloid cells, after the complete inhibition of the c-fes gene product and treatment with RA-DMSO, is due to activation of programmed cell death. It is concluded that a possible role of the c-fes gene product is to exert an antiapoptotic effect during granulocytic differentiation.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 52 条
[1]   OPTIMAL CONDITIONS FOR HYBRIDIZATION WITH OLIGONUCLEOTIDES - A STUDY WITH MYC-ONCOGENE DNA PROBES [J].
ALBRETSEN, C ;
HAUKANES, BI ;
AASLAND, R ;
KLEPPE, K .
ANALYTICAL BIOCHEMISTRY, 1988, 170 (01) :193-202
[2]  
ALCALAY M, 1990, ONCOGENE, V5, P267
[3]   TRANSLOCATION BREAKPOINT OF ACUTE PROMYELOCYTIC LEUKEMIA LIES WITHIN THE RETINOIC ACID RECEPTOR-ALPHA LOCUS [J].
ALCALAY, M ;
ZANGRILLI, D ;
PANDOLFI, PP ;
LONGO, L ;
MENCARELLI, A ;
GIACOMUCCI, A ;
ROCCHI, M ;
BIONDI, A ;
RAMBALDI, A ;
LOCOCO, F ;
DIVERIO, D ;
DONTI, E ;
GRIGNANI, F ;
PELICCI, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1977-1981
[4]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[5]   ELECTROPHORETIC TRANSFER OF PROTEINS AND NUCLEIC-ACIDS FROM SLAB GELS TO DIAZOBENZYLOXYMETHYL CELLULOSE OR NITROCELLULOSE SHEETS [J].
BITTNER, M ;
KUPFERER, P ;
MORRIS, CF .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (02) :459-471
[6]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[7]  
CEREZO L, 1982, AM J CLIN PATHOL, V77, P248
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   INHIBITION OF LEUKEMIA-CELL PROLIFERATION BY RECEPTOR-MEDIATED UPTAKE OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
CITRO, G ;
PERROTTI, D ;
CUCCO, C ;
DAGNANO, I ;
SACCHI, A ;
ZUPI, G ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :7031-7035
[10]  
COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94